Centene Corporation CNC | NYSE

$55.22 -$0.16 | -0.29%

Next Earnings: Jul 24, 2025

Company Overview:

Market Cap: $27.48B
PE Ratio: 8.14
52-Week Range: $54.01 - $80.59

10 Year CNC Performance Metrics:

Total Return (with DRIP): 42.0% (3.57% CAGR)
Total Return (no DRIP): 42.0% (3.57% CAGR)
Share Price: 42.0% (3.57% CAGR)
CNC Total Return
1Y 2Y 5Y 10Y

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

CNC Earnings, Revenue, Cash & Debt, Shares Outstaning:

CNC - Revenue
14-Day FREE Trial Get Full Access Now!
CNC Revenue CAGR:1Y: 15.38%2Y: 9.49%5Y: 12.37%10Y: 24.69%
CNC - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
CNC EPS CAGR:1Y: 21.76%2Y: 13.54%5Y: 101.08%10Y: 26.04%
CNC - Net Income
14-Day FREE Trial Get Full Access Now!
CNC Net Income CAGR:1Y: 12.73%2Y: 7.71%5Y: 95.42%10Y: 35.46%
CNC - EBITDA
14-Day FREE Trial Get Full Access Now!
CNC EBITDA CAGR:1Y: -2.19%2Y: 9.98%5Y: 28.45%10Y: 28.51%
CNC - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
CNC Free Cash Flow CAGR:1Y: 326.52%2Y: -41.69%5Y: 39.58%10Y: 54.28%
CNC - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
CNC Free Cash Flow / Share CAGR:1Y: 344.28%2Y: -38.57%5Y: 41.23%10Y: 43.32%
CNC - Operating Income
14-Day FREE Trial Get Full Access Now!
CNC Operating Income CAGR:1Y: 38.70%2Y: 12.22%5Y: 52.17%10Y: 28.09%
CNC - Gross Profit
14-Day FREE Trial Get Full Access Now!
CNC Gross Profit CAGR:1Y: 102.78%2Y: 43.50%5Y: 24.45%10Y: 31.99%
CNC - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
CNC Shares Outstanding CAGR:1Y: -7.41%2Y: -5.16%5Y: -2.03%10Y: 7.35%
CNC - Share Buybacks
14-Day FREE Trial Get Full Access Now!
CNC Share Buybacks CAGR:1Y: -72.85%2Y: -68.87%5Y: -40.68%10Y: 26.20%
CNC - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
CNC Stock-Based Comp CAGR:1Y: -15.71%2Y: -1.65%5Y: -12.80%10Y: 13.94%
CNC - Expenses
14-Day FREE Trial Get Full Access Now!
CNC Expenses CAGR:1Y: -10.60%2Y: -22.54%5Y: -5.27%10Y: 17.46%
CNC - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
CNC - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CNC - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
CNC - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CNC - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
CNC - Cash & Debt
14-Day FREE Trial Get Full Access Now!
CNC - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
CNC Revenue CAGR:1Y: 15.38%2Y: 9.49%5Y: 12.37%10Y: 24.69%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CNC - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CNC Actual Revenue CAGR:1Y: 15.38%2Y: 9.49%5Y: 12.37%10Y: 24.69%
CNC - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CNC Actual EPS CAGR:1Y: 21.76%2Y: 13.54%5Y: 101.08%10Y: 26.04%
CNC - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CNC Actual Net Income CAGR:1Y: 12.73%2Y: 7.71%5Y: 95.42%10Y: 35.46%
CNC - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CNC Actual EBITDA CAGR:1Y: -2.19%2Y: 9.98%5Y: 28.45%10Y: 28.51%

Ratios, Profit Margins & Return on Capital:

CNC - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
CNC Net Profit Margin CAGR:1Y: -2.43%2Y: -1.73%5Y: 73.26%10Y: 8.61%
CNC - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
CNC Gross Profit Margin CAGR:1Y: 75.65%2Y: 31.06%5Y: 10.76%10Y: 5.85%
CNC - Price to Earnings
14-Day FREE Trial Get Full Access Now!
CNC - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
CNC - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
CNC - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for CNC

Based on past 10-year performance, here are CNC growth metrics:

Share price CAGR of +3.89%
Dividend CAGR of +0%

Using CNC CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

CNC (DRIP)CNC - No DRIP
Current Price$55.22$55.22
Start Shares181.09181.09
Start Value$10,000$10,000
  
After 10 years:
Final Share Count181.09181.09
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$77.85$55.22
Total Dividends$0$0
Final Value$14,099$10,000

Estimated Future Value + Dividends - CNC

NOTE: Above numbers are our estimate based on CNC's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Centene Corporation (CNC) had its IPO on 2001-12-13, and is trader on NYSE stock exchange.

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

CNC website: https://www.centene.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial